Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Multiple Sclerosis News

News on Multiple Sclerosis continually updated from thousands of sources around the net.

22 hrs ago | Hartford Courant

Greater New Britain: Southington Teen Claims Adversity Tightened Bonds Of Love

People Submitted by Karen E. Butler on 2009-07-02.   Southington residents Jennifer Castonguay and her daughter Jessica Castonguay at the June 8 reception honoring the 2009 Hayley's Hope & Michaela's Miracle MS Scholarship recipients.

Comment?

Related Topix: Jennifer, Ballad, Southington, CT, New Britain, CT, Medicine, Health, Farmington, CT

Thu Jul 02, 2009

MediLexicon

Important Modulator Of Immune Cell Entry Into The Brain Discovered

Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.

Comment?

Related Topix: World News, Germany, Medicine, Health, Stanford, CA

Wed Jul 01, 2009

Med Ad News

Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement...

Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. Acorda to Continue to Develop and Commercialize Fampridine-SR in the U.S. Upfront Payment of $110 Million; Potential Deal Value Over $500 Million Acorda to Host Conference Call at 8:30 a.m. Eastern ...

Comment?

Related Topix: Biotech, Biogen Idec, Acorda Therapeutics, Medicine, Healthcare Industry, Health, Elan Corporation Plc

Science Blog

New clue into how brain stem cells develop into cells which repair damaged tissue

The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco and University of Cambridge and was published today in the journal Genes and Development.

Comment?

Related Topix: Medicine, Health, Charitable Organizations, Biotech, UC San Francisco

BioSpace

UCB Group and Biogen Idec, Inc. (Massachusetts) Discontinue Phase II Clinical Trial of CDP323

UCB and Biogen Idec announced today the discontinuation of the Phase II clinical trial of CDP323 for the treatment of relapsing multiple sclerosis .

Comment?

Related Topix: Biotech, Biogen Idec, Medicine, Health

Tue Jun 30, 2009

LancasterOnline

MS patient should find support elsewhe...

DEAR ANNIE: I am 49, the eldest of four siblings and have been suffering with multiple sclerosis for years.

Comment?

Related Topix: Medicine, Health

Fleetwood Today

MP Maclean set to stand down David Maclean, Conservative MP for...

David Maclean, Conservative MP for Penrith and the Border for 26 years, is to stand down at the next election.

Comment?

Related Topix: Medicine, Health

CiteULike

Modern multiple sclerosis treatment - what is approved, what is on the horizon.

NEW dalia NEW Abstract In the mid-1990s, the implementation of the immunomodulatory drugs interferon-beta and glatiramer acetate offered the first evidence-based treatment option for multiple sclerosis .

1 comment

Related Topix: Medicine, Health

Mon Jun 29, 2009

Triangle Business Journal

10th Tysabri PML case sinks Biogen shares

The Biogen Idec sign welcomes visitors to the company's RTP operations. Shares of Biogen Idec sunk Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.

Comment?

Related Topix: Biotech, Biogen Idec, Medicine, Health, Elan Corporation Plc, Food and Drug Administration

Science, Industry and Business

New Control System of the Body Discovered - Important Modulator of Immune Cell Entry into the Brain

Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.

Comment?

Related Topix: World News, Germany, Health, Stanford University, Stanford, CA

Sun Jun 28, 2009

Reuters

Novartis in talks to buy much of Elan: report

Swiss drugmaker Novartis is in talks to buy parts of Irish peer Elan , including its flagship multiple sclerosis products and its Alzheimer's disease pipeline, the Sunday Times said.

Comment?

Related Topix: Medicine, Health

Sat Jun 27, 2009

Institute of Food Technologists

Vitamin D Sufficiency Challenges and Opportunities for the Food Industry

Scientific evidence shows vitamin D may go beyond its traditionally known role in maintaining bone integrity, according to new research presented at the Institute of Food Technologists Annual Meeting and Food Expo earlier this month.

Comment?

Related Topix: Medicine, Health, Rheumatoid Arthritis, Life, Nutrition, Food

Thu Jun 25, 2009

MediLexicon

Figuring Out Who Will Benefit Most From A New Therapy For Multiple Sclerosis

In a recent phase II clinical trial, the drug alemtuzumab was found to be a highly effective treatment for individuals with early relapsing-remitting multiple sclerosis.

Comment?

Related Topix: Health, Medicine, Europe, World News, United Kingdom, Cambridgeshire County, England, University of Pennsylvania, Philadelphia, PA Metro

Wed Jun 24, 2009

Forfar Today

Rotary Donation Will Aid Research Into MS

THE Rotary Club of Kirriemuir has presented the Multiple Sclerosis Society of Scotland with a cheque for A 8,000, being the net proceeds from its Thrums Charity Dinner in April.

Comment?

Related Topix: Medicine, Health

News 10 Now

NYU study may find better treatments for MS

David Rice Jr. had not even reached his 40th birthday when he found out he had multiple sclerosis.

Comment?

Related Topix: Medicine, Health

PhysOrg Weblog

Advanced nerve cell system could help cure diabetic neuropathy, related diseases

Multiple sclerosis, diabetic neuropathy, and other conditions caused by a loss of myelin insulation around nerves can be debilitating and even deadly, but adequate treatments do not yet exist.

Comment?

Related Topix: Medicine, Health

Tue Jun 23, 2009

Western morning News

Court told man paid 25k for 'rubbish' data

A MAN who lost his investment in an alleged 700,000 business scam has told a court of his experience.

Comment?

Related Topix: Medicine, Health

Mon Jun 22, 2009

Contract Pharma Breaking News

Biogen Idec Begins Phase III Enrollment for RMS Drug

Biogen Idec has enrolled the first patient in a Phase III, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of PEGylated interferon beta-1a in patients with relapsing multiple sclerosis .

Comment?

Related Topix: Biotech, Biogen Idec, Medicine, Avonex, Interferon Beta-1a (generic), Medication, Health

Medical News Today

Researchers Piece Together More Of The Multiple Sclerosis Genetic Code

Main Category: Multiple Sclerosis Also Included In: Genetics Article Date: 17 Jun 2009 - 0:00 PDT Australian and New Zealand scientists are a step closer to unravelling what causes multiple sclerosis.

Comment?

Related Topix: Medicine, Health, Genetics, Biology, Science

Sat Jun 20, 2009

The Dispatch

Protecting Your Job While Coping With a Chronic Illness

Published: Saturday, June 20, 2009 at 5:13 a.m. Last Modified: Saturday, June 20, 2009 at 5:13 a.m. IT started with an odd sensation in her right hand and a feeling of exhaustion so profound she could hardly get through an hour of work, let alone a full day.

Comment?

Related Topix: Medicine, Health, Brooklyn Park, MN

↑ Back to top

More Multiple Sclerosis News

Archives

Read more articles in the Multiple Sclerosis News Archives.

For up to the minute news, check out the Multiple Sclerosis News Wire.

Want to add Multiple Sclerosis News headlines to your web site? Get the widget here.

RSS icon mobile icon

Multiple Sclerosis Photos

Vote on and add your comments to the latest Multiple Sclerosis photos from around the world

Multiple Sclerosis News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Multiple Sclerosis News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

Also on Topix